Live Chat

Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Jan 17, 11:25

Retireful LLC Makes New $260,000 Investment in BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Jan 17, 05:00

Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know

BioNTech SE
Webhose 2025 Jan 14, 11:53

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference | The Manila Times

BioNTech SE
Webhose 2025 Jan 10, 15:00

One biotech stock is 'oncology powerhouse' with 40% upside, says Truist

BioNTech SE
Webhose 2025 Jan 10, 13:38

BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Truist Financial

BioNTech SE
Webhose 2025 Jan 10, 01:25

Promising Oncology Pipeline and Financial Strength Drive BioNTech's Growth Prospects

BioNTech SE
Webhose 2025 Jan 10, 01:12

Truist rates BioNTech a Buy, citing 40% upside potential with key 2025 readouts By Investing.com

BioNTech SE
Webhose 2025 Jan 08, 02:10

Vaccine stocks rise in premarket trading amid a jump in number of flu cases By Investing.com

BioNTech SE
Webhose 2025 Jan 07, 19:43

Moderna Jumps 11% on Covid and Bird Flu News, Outperforming Falling Nasdaq 100

BioNTech SE
Webhose 2025 Jan 07, 17:43

BioNTech (NASDAQ:BNTX) Sees Strong Trading Volume - Time to Buy?

BioNTech SE
Webhose 2025 Jan 07, 16:19

BioNTech Sees Unusually Large Options Volume (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Jan 07, 15:50

Why Vaccine Stocks, Lucid (LCID) Are Rallying

BioNTech SE
Webhose 2025 Jan 07, 04:54

Moderna stock gains on rising flu cases By Investing.com

BioNTech SE
Webhose 2025 Jan 04, 09:30

Head-To-Head Review: Alector (NASDAQ:ALEC) and BioNTech (NASDAQ:BNTX)

BioNTech SE
Webhose 2025 Jan 03, 08:00

Penn expecting $467M from COVID-19 vaccine royalty dispute - WHYY

BioNTech SE
Webhose 2025 Jan 02, 22:01

Acuitas Fights GSK Claims on Pfizer, BioNTech's Covid-19 Shot

BioNTech SE
Webhose 2025 Jan 01, 08:24

Franklin Resources Inc. Sells 4,996 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE
Webhose 2024 Dec 30, 00:00

Biontech's $1.26B vaccine royalty settlement clears path forward | BioWorld

BioNTech SE
Webhose 2024 Dec 28, 19:47

BioNTech to pay $467M in settlement agreement with University of Pennsylvania

BioNTech SE
Webhose 2024 Dec 27, 16:39

BioNTech to Pay Up to $1.26 Billion in Covid-19 Vaccine Settlements With NIH, Penn | Morningstar

BioNTech SE
Webhose 2024 Dec 27, 15:11

BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties

BioNTech SE
Webhose 2024 Dec 27, 12:58

BioNTech settles with U.S. agency, University of Pennsylvania over Covid vaccine royalties

BioNTech SE
Webhose 2024 Dec 27, 11:51

BioNTech to Pay US, UPenn $1.3B in COVID Vaccine Royalties

BioNTech SE
Webhose 2024 Dec 27, 08:16

BioNTech SE (NASDAQ:BNTX) Receives $140.76 Consensus Target Price from Brokerages

BioNTech SE
Webhose 2024 Dec 27, 05:00

BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties | U.S. & World | gazette.com

BioNTech SE
Webhose 2024 Dec 27, 04:54

BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties By Reuters

BioNTech SE
Webhose 2024 Dec 22, 08:08

BioNTech SE (NASDAQ:BNTX) Receives Average Recommendation of "Moderate Buy" from Analysts

BioNTech SE
Webhose 2024 Dec 20, 04:46

BioNTech (NASDAQ:BNTX) Stock Price Up 2.9% – Time to Buy?

BioNTech SE

Latest news

Forex candlestick chart of JPY/USD currency pair trends.
Vanessa L 2025 Jan 17, 10:00

Forex Prop Trading Updates and Income Levels' Impact on Forex

Forex JPY USD
Bitcoin price action is shown on a trading chart, with a British flag in the background.
Vanessa L 2025 Jan 17, 09:00

Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK

Cryptocurrencies
Frances Wang 2025 Jan 16, 16:00

S&P 500 and Nasdaq 100 Update: Strong Earnings Drive Market Gains

Indices
Frances Wang 2025 Jan 16, 16:00

Oil price today: Oil Prices Climb Amid Supply Fears

Oil
Frances Wang 2025 Jan 16, 16:00

Forex market update: GBP/USD, USD/JPY Forecast

Forex
Darius Anucauskas 2025 Jan 16, 16:00

Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration

The person silhouette with fluctuating red and green stock charts, symbolizes uncertainty.
Vanessa L 2025 Jan 16, 11:00

Why Is the Stock Market Going Down Today and Are Interest Rates Going Down?

Stocks Shares
A tanker carrying heating oil on a foggy morning, symbolizes the global energy trade.
Vanessa L 2025 Jan 16, 09:02

What Influences the Price of Heating Oil Per Gallon Today? Insights on Futures Contract Crude Oil

Oil Commodities

Info

Spread

1.1513

Spread (%)

1.0343 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

14:31 - 20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

27033083904

Shares Outstanding

239740000

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-2

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A, as well as strategic partnership the Coalition for Epidemic Preparedness Innovations (CEPI) to strengthen africa's mrna vac

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments
Trustpilot
Live Chat